Evidence map›Paper›PMID 37069344›Full record

ArticleMolecular psychiatry2023

Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics.

Renata Batista-Brito, Antara Majumdar, Alejandro Nuño, Claire Ward, Clayton Barnes, Kasra Nikouei, Martin Vinck, Jessica A Cardin

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Interneuron Diversity: How Form Becomes Function.Cold Spring Harbor perspectives in biology · 2025
    Review
  8. Review
  9. Parvalbumin interneuron deficits in schizophrenia.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2024
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Renata Batista-BritoDepartment of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY, 10461, USA. renata.brito@einsteinmed.edu.
Antara MajumdarDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA.ORCID 0000-0001-9777-6400
Alejandro NuñoDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA.
Claire WardDepartment of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY, 10461, USA.
Clayton BarnesDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA.ORCID 0000-0003-2471-6268
Kasra NikoueiDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA.
Martin VinckDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA.ORCID 0000-0002-4044-0970
Jessica A CardinDepartment of Neuroscience, Yale University School of Medicine, 333 Cedar St., New Haven, CT, 06520, USA. jess.cardin@yale.edu.ORCID 0000-0002-8209-5466
Yale University · USAlbert Einstein College of Medicine · USKarolinska Institutet · SE

Funding

Yale Core Grant for Vision ResearchP30EY026878 · NEI · YALE UNIVERSITY · PI Z JIMMY ZHOU · 2016 to 2026
$7.1M
Inhibitory regulation of cortical visual processingR01EY022951 · NEI · YALE UNIVERSITY · PI CARDIN, JESSICA A · 2013 to 2025
$4.0M
GABAergic contributions to neural circuit deficits in schizophreniaR01MH102365 · NIMH · YALE UNIVERSITY · PI CARDIN, JESSICA A · 2014 to 2018
$2.1M
Developmental Dysfunction of Parvalbumin Interneurons in Autism Spectrum DisorderF31HD101360 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI WARD, CLAIRE · 2020 to 2024
$235k
NEI NIH HHS P30 EY026878NEI NIH HHS R01 EY022951NICHD NIH HHS F31 HD101360NIMH NIH HHS R01 MH102365
6 · The paper itself

Abstract

GABAergic inhibition plays an important role in the establishment and maintenance of cortical circuits during development. Neuregulin 1 (Nrg1) and its interneuron-specific receptor ErbB4 are key elements of a signaling pathway critical for the maturation and proper synaptic connectivity of interneurons. Using conditional deletions of the ERBB4 gene in mice, we tested the role of this signaling pathway at two developmental timepoints in parvalbumin-expressing (PV) interneurons, the largest subpopulation of cortical GABAergic cells. Loss of ErbB4 in PV interneurons during embryonic, but not late postnatal development leads to alterations in the activity of excitatory and inhibitory cortical neurons, along with severe disruption of cortical temporal organization. These impairments emerge by the end of the second postnatal week, prior to the complete maturation of the PV interneurons themselves. Early loss of ErbB4 in PV interneurons also results in profound dysregulation of excitatory pyramidal neuron dendritic architecture and a redistribution of spine density at the apical dendritic tuft. In association with these deficits, excitatory cortical neurons exhibit normal tuning for sensory inputs, but a loss of state-dependent modulation of the gain of sensory responses. Together these data support a key role for early developmental Nrg1/ErbB4 signaling in PV interneurons as a powerful mechanism underlying the maturation of both the inhibitory and excitatory components of cortical circuits.

Indexed as

Pyramidal CellsSignal TransductionAnimalsInterneuronsMiceNeuregulin-1NeuronsParvalbuminsReceptor, ErbB-4Erbb4 protein, mouseNeuregulin-1ParvalbuminsReceptor, ErbB-4

Identifiers

PMID37069344
PMCPMC10618960
OpenAlexW4366190504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.